Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and… Read more
Eurofins-Cerep SA (ALECR) - Total Assets
Latest total assets as of June 2025: €84.58 Million EUR
Based on the latest financial reports, Eurofins-Cerep SA (ALECR) holds total assets worth €84.58 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Eurofins-Cerep SA - Total Assets Trend (2000–2024)
This chart illustrates how Eurofins-Cerep SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Eurofins-Cerep SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Eurofins-Cerep SA's total assets of €84.58 Million consist of 86.4% current assets and 13.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 20.9% |
| Accounts Receivable | €51.16 Million | 60.9% |
| Inventory | €3.36 Million | 4.0% |
| Property, Plant & Equipment | €8.66 Million | 10.3% |
| Intangible Assets | €202.30K | 0.2% |
| Goodwill | €2.23 Million | 2.7% |
Asset Composition Trend (2000–2024)
This chart illustrates how Eurofins-Cerep SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eurofins-Cerep SA's current assets represent 86.4% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 20.9% of total assets in 2024, up from 8.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 60.9% of total assets.
Eurofins-Cerep SA Competitors by Total Assets
Key competitors of Eurofins-Cerep SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Eurofins-Cerep SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Eurofins-Cerep SA generates 0.48x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Eurofins-Cerep SA generates $8.51 in net profit.
Eurofins-Cerep SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.34 | 7.64 | 4.58 |
| Quick Ratio | 7.97 | 7.18 | 4.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €65.03 Million | € 57.72 Million | € 27.25 Million |
Eurofins-Cerep SA - Advanced Valuation Insights
This section examines the relationship between Eurofins-Cerep SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.23 |
| Latest Market Cap to Assets Ratio | 1.11 |
| Asset Growth Rate (YoY) | 6.1% |
| Total Assets | €84.06 Million |
| Market Capitalization | $93.20 Million USD |
Valuation Analysis
Above Book Valuation: The market values Eurofins-Cerep SA's assets above their book value (1.11 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Eurofins-Cerep SA's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Eurofins-Cerep SA (2000–2024)
The table below shows the annual total assets of Eurofins-Cerep SA from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €84.06 Million | +6.07% |
| 2023-12-31 | €79.25 Million | +11.54% |
| 2022-12-31 | €71.05 Million | +18.95% |
| 2021-12-31 | €59.73 Million | +29.67% |
| 2020-12-31 | €46.06 Million | +15.30% |
| 2019-12-31 | €39.95 Million | +13.31% |
| 2018-12-31 | €35.26 Million | +16.83% |
| 2017-12-31 | €30.18 Million | +16.33% |
| 2016-12-31 | €25.94 Million | +3.02% |
| 2015-12-31 | €25.18 Million | +9.97% |
| 2014-12-31 | €22.90 Million | -17.89% |
| 2013-12-31 | €27.89 Million | -7.92% |
| 2012-12-31 | €30.28 Million | -7.45% |
| 2011-12-31 | €32.72 Million | -8.84% |
| 2010-12-31 | €35.90 Million | -18.98% |
| 2009-12-31 | €44.31 Million | -19.30% |
| 2008-12-31 | €54.91 Million | -12.47% |
| 2007-12-31 | €62.73 Million | -17.86% |
| 2006-12-31 | €76.37 Million | -8.70% |
| 2005-12-31 | €83.65 Million | +30.95% |
| 2004-12-31 | €63.87 Million | +24.65% |
| 2003-12-31 | €51.24 Million | +7.39% |
| 2002-12-31 | €47.72 Million | +16.67% |
| 2001-12-31 | €40.90 Million | +72.80% |
| 2000-12-31 | €23.67 Million | -- |